120 related articles for article (PubMed ID: 2111726)
1. HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.
Remis RS; O'Shaughnessy MV; Tsoukas C; Growe GH; Schechter MT; Palmer RW; Lawrence DN
CMAJ; 1990 Jun; 142(11):1247-54. PubMed ID: 2111726
[TBL] [Abstract][Full Text] [Related]
2. Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate.
Schimpf K; Brackmann HH; Kreuz W; Kraus B; Haschke F; Schramm W; Moesseler J; Auerswald G; Sutor AH; Koehler K
N Engl J Med; 1989 Oct; 321(17):1148-52. PubMed ID: 2507917
[TBL] [Abstract][Full Text] [Related]
3. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.
Schimpf K; Mannucci PM; Kreutz W; Brackmann HH; Auerswald G; Ciavarella N; Mösseler J; DeRosa V; Kraus B; Brueckmann C
N Engl J Med; 1987 Apr; 316(15):918-22. PubMed ID: 3102963
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of four Chinese hemophiliacs with human immunodeficiency virus infection.
Tang DJ; Xu YH; Dai D; Han YJ; Wang BC; Lang YM; Liang Y; Zeng Y
Chin Med J (Engl); 1989 Nov; 102(11):819-24. PubMed ID: 2517721
[TBL] [Abstract][Full Text] [Related]
5. HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates.
Wolfs TF; Breederveld C; Krone WJ; vd Hoek L; Bakker M; Smit L; Goudsmit J
Thromb Haemost; 1988 Jun; 59(3):396-9. PubMed ID: 3142077
[TBL] [Abstract][Full Text] [Related]
6. HIV seroconversion in Thai hemophiliacs up to 1991.
Isarangkura P; Chuansumrit A; Hathirat P; Panthangkura W; Mahaphan W; Limsuwan A; Chiewsilp P
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():191-4. PubMed ID: 7886571
[TBL] [Abstract][Full Text] [Related]
7. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
[TBL] [Abstract][Full Text] [Related]
8. Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.
Mokhbat JE; Naman RE; Rahme FS; Farah AE; Zahar KL; Maalouf A
J Med Liban; 1989; 38(1):9-14. PubMed ID: 2519339
[TBL] [Abstract][Full Text] [Related]
9. [Transmission of the human immunodeficiency virus by a dry heat-treated Factor VIII concentrate?].
Weisser J
Klin Padiatr; 1988; 200(5):375-9. PubMed ID: 3141670
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-related human immunodeficiency virus in patients with haemophilia in Johannesburg.
Cohn RJ; MacPhail AP; Hartman E; Schwyzer R; Sher R
S Afr Med J; 1990 Dec; 78(11):653-6. PubMed ID: 2123569
[TBL] [Abstract][Full Text] [Related]
11. The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies.
Mannucci PM; Santagostino E; Di Bona E; Gentili G; Ghirardini A; Schiavoni M; Mele A
Vox Sang; 1994; 67 Suppl 1():31-5. PubMed ID: 8091734
[TBL] [Abstract][Full Text] [Related]
12. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
Heimburger N; Karges HE; Weidmann E
Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV seroconversion in hemophilia A patient after transfusion of anti-HIV negative blood components.
Ungkanont A; Atichartakarn V; Chiewsilp P
J Med Assoc Thai; 1992 Feb; 75(2):120-2. PubMed ID: 1645050
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
Parquet A; Boneu B; Bosser C; Cazenave JP; Dirat G; Gazengel G; Grunebaum L; Sultan Y; Verroust F; Wiesel ML
Nouv Rev Fr Hematol (1978); 1988; 30(4):205-7. PubMed ID: 3143099
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Jan; 45(2):29-32. PubMed ID: 8531917
[TBL] [Abstract][Full Text] [Related]
16. AIDS and haemophilia.
Bloom AL
Biomed Pharmacother; 1985; 39(7):355-65. PubMed ID: 3938297
[TBL] [Abstract][Full Text] [Related]
17. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
Smid WM; van der Meer J; Smit JW; Halie MR
Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
[TBL] [Abstract][Full Text] [Related]
18. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
[TBL] [Abstract][Full Text] [Related]
19. [Human immunodeficiency virus infection in hemophiliacs: prevalence and current clinical situation].
Lorenzo JI; Molina R; Arilla MJ; Dasí MA; Monteagudo E; Aznar JA
Sangre (Barc); 1991 Dec; 36(6):451-5. PubMed ID: 1812578
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HIV-antibodies in patients with haemophilia in Hungary.
Ujhelyi E; Králl G; Füst G; Medgyesi GA; Hollán SR; Zimonyi I; Berkessy S; Nagy K; Földes I; Mayer V
Haematologia (Budap); 1988; 21(2):83-9. PubMed ID: 3262077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
